A study led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found that a group of prostate cancer patients reliably reported their own medical histories when their responses were compared ...
Feb 17, 2017
0
2
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients ...
Apr 17, 2012
0
0
Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.
Oct 16, 2012
0
0
Research using electronic clinical data (ECD) has the potential to make major contributions to health care research and improve patient outcomes. However, many complex issues remain unanswered. A special August supplement ...
Jul 16, 2013
0
0
UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities – the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) ...
May 15, 2013
0
0
(Medical Xpress)—While many Americans deeply mistrust government, and are generally suspicious of health insurance companies and the pharmaceutical industry, they overwhelmingly trust physicians and view them as faithful ...
Jun 17, 2013
0
0
Comparative effectiveness research conducted over the past decade has had a limited impact on the way medical care is delivered, but many opportunities exist to help doctors and others in the medical system translate such ...
Oct 9, 2012
0
0
The American College of Physicians (ACP) today released a new policy paper calling for changes that could slow the rising cost of prescription drugs. The paper, Stemming the Escalating Cost of Prescription Drugs, was published ...
Mar 28, 2016
0
0
More Hispanic Texans die from cancer than any other cause, according to a new report by the Comparative Effectiveness Research on Cancer in Texas research group.
Sep 30, 2013
0
0
Comparison of two of the most commonly prescribed drugs for infants with nonsyndromic epilepsy revealed that levetiracetam was more effective than phenobarbital, according a multicenter, observational study published in JAMA ...
Feb 12, 2018
0
2
